Macquarie Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $121M | Sell |
|
|||||
|
2025
Q2 | $87.1M | Buy |
|
|||||
|
2025
Q1 | $88.4M | Buy |
|
|||||
|
2024
Q4 | $95.1M | Sell |
|
|||||
|
2024
Q3 | $82.1M | Sell |
|
|||||
|
2024
Q2 | $71.7M | Buy |
|
|||||
|
2024
Q1 | $91M | Sell |
|
|||||
|
2023
Q4 | $79.2M | Sell |
|
|||||
|
2023
Q3 | $75.8M | Buy |
|
|||||
|
2023
Q2 | $75.3M | Buy |
|
|||||
|
2023
Q1 | $89.6M | Buy |
|
|||||
|
2022
Q4 | $86.3M | Buy |
|
|||||
|
2022
Q3 | $80.2M | Buy |
|
|||||
|
2022
Q2 | $67.6M | Buy |
|
|||||
|
2022
Q1 | $75K | Buy |
|
|||||
|
2021
Q4 | $63.3M | Buy |
|
|||||
|
2021
Q3 | $57M | Buy |
|
|||||
|
2021
Q2 | $65.8M | Buy |
|
|||||
|
2021
Q1 | $54.6M | Sell |
|
|||||
|
2020
Q4 | $55.6M | Buy |
|
|||||
|
2020
Q3 | $42.7M | Buy |
|
|||||
|
2020
Q2 | $44.5M | Buy |
|
|||||
|
2020
Q1 | $31.1M | Buy |
|
|||||
|
2019
Q4 | $35.7M | Buy |
|
|||||
|
2019
Q3 | $36.3M | Buy |
|
|||||
|
2019
Q2 | $35.7M | Buy |
|
|||||
|
2019
Q1 | $34.8M | Buy |
|
|||||
|
2018
Q4 | $24.8M | Buy |
|
|||||
|
2018
Q3 | $28.6M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $3.61M | Sell |
|
|||||
|
2017
Q4 | $4.09M | Buy |
|
|||||
|
2017
Q3 | $3.49M | Sell |
|
|||||
|
2017
Q2 | $7.01M | Buy |
|
|||||
|
2017
Q1 | $5.02M | Sell |
|
|||||
|
2016
Q4 | $4.11M | Sell |
|
|||||
|
2016
Q3 | $5.95M | Sell |
|
|||||
|
2016
Q2 | $5.93M | Buy |
|
|||||
|
2016
Q1 | $1.96M | Buy |
|